28929339|t|Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer's Rat Model.
28929339|a|Intracerebroventricular injection of streptozotocin (ICV-STZ) in rodents leads to cognitive impairments and several pathological changes like Alzheimer's disease (AD). However, there is hardly any research about the effect of ICV-STZ on regional cerebral glucose metabolism in rodents. Previous studies have demonstrated that intranasal insulin improves cognition in AD patients. However, the underlying mechanism remains elusive. Here, we treated the ICV-STZ rats with daily intranasal delivery of insulin (2 U/day) for 6 consecutive weeks, then monitored 18F-fluorodeoxyglucose (18F-FDG) uptake using a high-resolution small-animal positron emission tomography (microPET) and studied the expression of neuronal nuclei (NeuN) and glial fibrillary acidic protein (GFAP) using immunohistochemical staining. We observed that 18F-FDG uptake decreased significantly at the prefrontal cortex, cingulate cortex, striatum, hippocampus, and entorhinal cortex in ICV-STZ rats as compared with the control rats. Intranasal insulin restores the cerebral glucose metabolism in prefrontal and cingulate cortex and attenuates astroglia activation and neuronal loss in the hippocampus of ICV-STZ rats. These findings provide the mechanistic basis for treating AD patients with intranasal insulin.
28929339	31	54	Cerebral Hypometabolism	Disease	MESH:D002547
28929339	56	69	Neuronal Loss	Disease	MESH:D009410
28929339	75	87	Astrogliosis	Disease	MESH:D005911
28929339	91	105	Streptozotocin	Chemical	MESH:D013311
28929339	114	125	Alzheimer's	Disease	MESH:D000544
28929339	126	129	Rat	Species	10116
28929339	174	188	streptozotocin	Chemical	MESH:D013311
28929339	194	197	STZ	Chemical	MESH:D013311
28929339	219	240	cognitive impairments	Disease	MESH:D003072
28929339	279	298	Alzheimer's disease	Disease	MESH:D000544
28929339	300	302	AD	Disease	MESH:D000544
28929339	367	370	STZ	Chemical	MESH:D013311
28929339	392	399	glucose	Chemical	MESH:D005947
28929339	504	506	AD	Disease	MESH:D000544
28929339	507	515	patients	Species	9606
28929339	593	596	STZ	Chemical	MESH:D013311
28929339	597	601	rats	Species	10116
28929339	694	716	18F-fluorodeoxyglucose	Chemical	MESH:D019788
28929339	718	725	18F-FDG	Chemical	MESH:D019788
28929339	868	899	glial fibrillary acidic protein	Gene	24387
28929339	901	905	GFAP	Gene	24387
28929339	960	967	18F-FDG	Chemical	MESH:D019788
28929339	1095	1098	STZ	Chemical	MESH:D013311
28929339	1099	1103	rats	Species	10116
28929339	1133	1137	rats	Species	10116
28929339	1180	1187	glucose	Chemical	MESH:D005947
28929339	1274	1287	neuronal loss	Disease	MESH:D009410
28929339	1314	1317	STZ	Chemical	MESH:D013311
28929339	1318	1322	rats	Species	10116
28929339	1382	1384	AD	Disease	MESH:D000544
28929339	1385	1393	patients	Species	9606
28929339	Negative_Correlation	MESH:D013311	MESH:D019788
28929339	Positive_Correlation	MESH:D013311	MESH:D003072
28929339	Positive_Correlation	MESH:D013311	MESH:D000544
28929339	Association	MESH:D005947	MESH:D013311

